CROWN CASTLE INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CROWN CASTLE INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.26B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $4.46B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $4.73B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $6.99B | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $6.34B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $5.84B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $1.43B | Mar 10, 2020 |
| FY2019 | Sep 30, 2019 | $1.48B | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $1.45B | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $1.41B | Mar 10, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $192.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $421.00M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $697.00M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $621.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $520.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $670.00M | Feb 22, 2022 |
| FY2019 | Sep 30, 2019 | $195.00M | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $184.00M | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $166.00M | Mar 10, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.24B | Feb 26, 2018 |
| FY2017 | Sep 30, 2017 | $1.06B | Feb 26, 2018 |
| FY2017 | Jun 30, 2017 | $1.04B | Feb 26, 2018 |
| FY2017 | Mar 31, 2017 | $1.02B | Feb 26, 2018 |
| FY2017 | Dec 31, 2016 | $1.03B | Feb 26, 2018 |
| FY2017 | Sep 30, 2016 | $992.02M | Feb 26, 2018 |
| FY2017 | Jun 30, 2016 | $962.41M | Feb 26, 2018 |
| FY2017 | Mar 31, 2016 | $934.38M | Feb 26, 2018 |
| FY2016 | Dec 31, 2015 | $945.84M | Feb 22, 2017 |
| FY2016 | Sep 30, 2015 | $918.11M | Feb 22, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $444.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | ($3.90B) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $1.50B | Feb 23, 2026 |
| FY2019 | Dec 31, 2019 | $208.00M | Mar 10, 2020 |
| FY2018 | Dec 31, 2018 | $185.00M | Feb 25, 2019 |
| FY2018 | Sep 30, 2018 | $136.00M | Feb 25, 2019 |
| FY2018 | Jun 30, 2018 | $152.00M | Feb 25, 2019 |
| FY2018 | Mar 31, 2018 | $86.00M | Feb 25, 2019 |
| FY2018 | Dec 31, 2017 | $98.00M | Feb 25, 2019 |
| FY2018 | Sep 30, 2017 | $115.00M | Feb 25, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.08B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $2.12B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $2.10B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $2.43B | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $2.00B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.86B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $379.00M | Mar 10, 2020 |
| FY2019 | Sep 30, 2019 | $423.00M | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $389.00M | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $367.00M | Mar 10, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $383.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $435.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $502.00M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $750.00M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $680.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $678.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $614.00M | Feb 22, 2022 |
| FY2019 | Sep 30, 2019 | $150.00M | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $155.00M | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $152.00M | Mar 10, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.06B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $2.94B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $3.13B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $2.88B | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $2.79B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $3.06B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $2.70B | Feb 22, 2022 |
| FY2019 | Sep 30, 2019 | $1.89B | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $1.23B | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $512.00M | Mar 10, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.52B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $32.74B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $38.53B | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $38.92B | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $39.04B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $38.77B | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $38.46B | Feb 22, 2021 |
| FY2019 | Sep 30, 2019 | $38.32B | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $38.12B | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $37.76B | Mar 10, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.15B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $32.87B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $32.15B | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $31.47B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $30.78B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $29.31B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $27.97B | Feb 22, 2021 |
| FY2019 | Sep 30, 2019 | $27.54B | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $27.11B | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $26.49B | Mar 10, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $7.09B | Feb 22, 2016 |
| FY2015 | Dec 31, 2014 | $6.72B | Feb 22, 2016 |
| FY2014 | Dec 31, 2013 | $6.93B | Feb 19, 2015 |
| FY2013 | Dec 31, 2012 | $2.94B | Feb 24, 2014 |
| FY2012 | Dec 31, 2011 | $2.39B | Feb 12, 2013 |
| FY2011 | Dec 31, 2010 | $2.45B | Feb 13, 2012 |
| FY2010 | Dec 31, 2009 | $2.94B | Feb 17, 2011 |
| FY2009 | Dec 31, 2008 | $2.72B | Feb 16, 2010 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.13B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $5.13B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $10.09B | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $10.09B | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $10.08B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $10.08B | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $10.08B | Feb 22, 2021 |
| FY2019 | Sep 30, 2019 | $10.08B | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $10.08B | Mar 10, 2020 |
| FY2019 | Dec 31, 2018 | $10.08B | Mar 10, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($20.16B) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | ($18.53B) | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | ($11.89B) | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | ($10.67B) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($9.75B) | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | ($8.47B) | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | ($7.37B) | Feb 22, 2021 |
| FY2019 | Sep 30, 2019 | ($7.04B) | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | ($6.79B) | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | ($6.50B) | Mar 10, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $100.00M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $105.00M | Mar 14, 2025 |
| FY2024 | Dec 31, 2022 | $156.00M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $292.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $232.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $196.00M | Feb 22, 2022 |
| FY2019 | Sep 30, 2019 | $182.00M | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | $288.00M | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | $245.00M | Mar 10, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.34B | Feb 23, 2026 |
| FY2024 | Dec 31, 2024 | $24.08B | Mar 14, 2025 |
| FY2023 | Dec 31, 2023 | $22.92B | Feb 23, 2024 |
| FY2022 | Dec 31, 2022 | $21.73B | Feb 24, 2023 |
| FY2021 | Dec 31, 2021 | $20.63B | Feb 22, 2022 |
| FY2020 | Dec 31, 2020 | $19.28B | Feb 22, 2021 |
| FY2019 | Dec 31, 2019 | $18.12B | Mar 10, 2020 |
| FY2018 | Dec 31, 2018 | $16.68B | Feb 25, 2019 |
| FY2017 | Dec 31, 2017 | $16.16B | Feb 26, 2018 |
| FY2016 | Dec 31, 2016 | $12.17B | Feb 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | (8) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 10, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 10, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | (8) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 10, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 10, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 435.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | 435.00M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | 434.00M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | 433.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 432.00M | Feb 24, 2023 |
| FY2020 | Dec 31, 2020 | 431.00M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 416.00M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | 415.00M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | 406.00M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 360.54M | Feb 26, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.08B) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | ($2.73B) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | ($2.72B) | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | ($2.60B) | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $2.37B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.11B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.91B | Feb 22, 2022 |
| FY2019 | Sep 30, 2019 | ($1.42B) | Mar 10, 2020 |
| FY2019 | Jun 30, 2019 | ($944.00M) | Mar 10, 2020 |
| FY2019 | Mar 31, 2019 | ($477.00M) | Mar 10, 2020 |